Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)

Abstract Background The pathophysiology of chemotherapy-induced peripheral neuropathy (CIPN) is not well understood. Currently, dose reduction is the only recommendation for alleviating symptoms, often leading to premature treatment cessation. The primary aim of this analysis was to determine the as...

Full description

Bibliographic Details
Main Authors: Jennifer M. Mongiovi, Gary R. Zirpoli, Rikki Cannioto, Lara E. Sucheston-Campbell, Dawn L. Hershman, Joseph M. Unger, Halle C. F. Moore, James A. Stewart, Claudine Isaacs, Timothy J. Hobday, Muhammad Salim, Gabriel N. Hortobagyi, Julie R. Gralow, G. Thomas Budd, Kathy S. Albain, Christine B. Ambrosone, Susan E. McCann
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Breast Cancer Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13058-018-1077-9
_version_ 1818960426865524736
author Jennifer M. Mongiovi
Gary R. Zirpoli
Rikki Cannioto
Lara E. Sucheston-Campbell
Dawn L. Hershman
Joseph M. Unger
Halle C. F. Moore
James A. Stewart
Claudine Isaacs
Timothy J. Hobday
Muhammad Salim
Gabriel N. Hortobagyi
Julie R. Gralow
G. Thomas Budd
Kathy S. Albain
Christine B. Ambrosone
Susan E. McCann
author_facet Jennifer M. Mongiovi
Gary R. Zirpoli
Rikki Cannioto
Lara E. Sucheston-Campbell
Dawn L. Hershman
Joseph M. Unger
Halle C. F. Moore
James A. Stewart
Claudine Isaacs
Timothy J. Hobday
Muhammad Salim
Gabriel N. Hortobagyi
Julie R. Gralow
G. Thomas Budd
Kathy S. Albain
Christine B. Ambrosone
Susan E. McCann
author_sort Jennifer M. Mongiovi
collection DOAJ
description Abstract Background The pathophysiology of chemotherapy-induced peripheral neuropathy (CIPN) is not well understood. Currently, dose reduction is the only recommendation for alleviating symptoms, often leading to premature treatment cessation. The primary aim of this analysis was to determine the association between components of diet during taxane treatment for breast cancer and change in CIPN symptoms over treatment. Methods Women with stage II or III invasive breast cancer were enrolled into an ancillary study to the North American Breast Cancer Intergroup phase III trial (S0221) led by the Southwest Oncology Group (SWOG). Questionnaires including a food frequency questionnaire and the Functional Assessment of Cancer Treatment Gynecologic Oncology Group—Neurotoxicity were administered to assess diet and neuropathic conditions at baseline and during chemotherapy. Ordinal regression was used to estimate odds ratios (ORs) for associations between various food groups and change in neuropathy score (< 10%, 10–30%, > 30%) (n = 900). Results The odds of worse neuropathy decreased by 21% for each increase in tertile of grain consumption (OR = 0.79, 95% CI 0.66–0.94, p = 0.009). We also observed a nominal 19% increase with higher consumption of citrus fruits (OR = 1.19, 95% CI 1.01–1.40, p = 0.05). Conclusions Distinguishing between those who experienced a moderate and a severe change in neuropathy, we found that citrus fruit and grain consumption may play a role in the severity of symptoms. Since there are no existing dietary recommendations for the management of CIPN, further research is needed to investigate whether there may be certain foods that could worsen or alleviate neuropathy symptoms associated with treatment for breast cancer. Trial registration ClinicalTrials.gov, NCT03413761. Registered retrospectively on 29 January 2018.
first_indexed 2024-12-20T11:57:21Z
format Article
id doaj.art-9d0a7a1284e54998b733c15ed2ca4e29
institution Directory Open Access Journal
issn 1465-542X
language English
last_indexed 2024-12-20T11:57:21Z
publishDate 2018-11-01
publisher BMC
record_format Article
series Breast Cancer Research
spelling doaj.art-9d0a7a1284e54998b733c15ed2ca4e292022-12-21T19:41:37ZengBMCBreast Cancer Research1465-542X2018-11-0120111210.1186/s13058-018-1077-9Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)Jennifer M. Mongiovi0Gary R. Zirpoli1Rikki Cannioto2Lara E. Sucheston-Campbell3Dawn L. Hershman4Joseph M. Unger5Halle C. F. Moore6James A. Stewart7Claudine Isaacs8Timothy J. Hobday9Muhammad Salim10Gabriel N. Hortobagyi11Julie R. Gralow12G. Thomas Budd13Kathy S. Albain14Christine B. Ambrosone15Susan E. McCann16University at BuffaloBoston UniversityRoswell Park Cancer InstituteThe Ohio State UniversityColumbia UniversitySWOG Statistical Center, Fred Hutchinson Cancer Research CenterCleveland ClinicBaystate Medical CenterGeorgetown UniversityMayo ClinicAllan Blair Cancer CentreThe University of Texas MD Anderson Cancer CenterSeattle Cancer Care AllianceCleveland ClinicLoyola University Chicago Stritch School of MedicineRoswell Park Cancer InstituteRoswell Park Cancer InstituteAbstract Background The pathophysiology of chemotherapy-induced peripheral neuropathy (CIPN) is not well understood. Currently, dose reduction is the only recommendation for alleviating symptoms, often leading to premature treatment cessation. The primary aim of this analysis was to determine the association between components of diet during taxane treatment for breast cancer and change in CIPN symptoms over treatment. Methods Women with stage II or III invasive breast cancer were enrolled into an ancillary study to the North American Breast Cancer Intergroup phase III trial (S0221) led by the Southwest Oncology Group (SWOG). Questionnaires including a food frequency questionnaire and the Functional Assessment of Cancer Treatment Gynecologic Oncology Group—Neurotoxicity were administered to assess diet and neuropathic conditions at baseline and during chemotherapy. Ordinal regression was used to estimate odds ratios (ORs) for associations between various food groups and change in neuropathy score (< 10%, 10–30%, > 30%) (n = 900). Results The odds of worse neuropathy decreased by 21% for each increase in tertile of grain consumption (OR = 0.79, 95% CI 0.66–0.94, p = 0.009). We also observed a nominal 19% increase with higher consumption of citrus fruits (OR = 1.19, 95% CI 1.01–1.40, p = 0.05). Conclusions Distinguishing between those who experienced a moderate and a severe change in neuropathy, we found that citrus fruit and grain consumption may play a role in the severity of symptoms. Since there are no existing dietary recommendations for the management of CIPN, further research is needed to investigate whether there may be certain foods that could worsen or alleviate neuropathy symptoms associated with treatment for breast cancer. Trial registration ClinicalTrials.gov, NCT03413761. Registered retrospectively on 29 January 2018.http://link.springer.com/article/10.1186/s13058-018-1077-9Chemotherapy-induced peripheral neuropathyBreast cancerDietTaxanePeripheral nervous system diseases
spellingShingle Jennifer M. Mongiovi
Gary R. Zirpoli
Rikki Cannioto
Lara E. Sucheston-Campbell
Dawn L. Hershman
Joseph M. Unger
Halle C. F. Moore
James A. Stewart
Claudine Isaacs
Timothy J. Hobday
Muhammad Salim
Gabriel N. Hortobagyi
Julie R. Gralow
G. Thomas Budd
Kathy S. Albain
Christine B. Ambrosone
Susan E. McCann
Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
Breast Cancer Research
Chemotherapy-induced peripheral neuropathy
Breast cancer
Diet
Taxane
Peripheral nervous system diseases
title Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
title_full Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
title_fullStr Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
title_full_unstemmed Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
title_short Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221)
title_sort associations between self reported diet during treatment and chemotherapy induced peripheral neuropathy in a cooperative group trial s0221
topic Chemotherapy-induced peripheral neuropathy
Breast cancer
Diet
Taxane
Peripheral nervous system diseases
url http://link.springer.com/article/10.1186/s13058-018-1077-9
work_keys_str_mv AT jennifermmongiovi associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT garyrzirpoli associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT rikkicannioto associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT laraesuchestoncampbell associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT dawnlhershman associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT josephmunger associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT hallecfmoore associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT jamesastewart associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT claudineisaacs associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT timothyjhobday associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT muhammadsalim associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT gabrielnhortobagyi associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT juliergralow associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT gthomasbudd associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT kathysalbain associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT christinebambrosone associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221
AT susanemccann associationsbetweenselfreporteddietduringtreatmentandchemotherapyinducedperipheralneuropathyinacooperativegrouptrials0221